HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic administration of methylphenidate did not affect memory and GDNF levels but increase astrogliosis in adult male rat's hippocampus.

AbstractBACKGROUND:
ADHD is the most common developmental disorder affecting approximately three to seven percent of school-aged children and 2.5 percent of adults worldwide. The drug of choice for the pharmacotherapy of ADHD is Methylphenidate (MPH). However, there is growing concerns about side effects resulting from its potential interference with brain anatomical and behavioral development.
AIM:
This article focuses on the adverse effects of MPH on the rat's hippocampus.
METHODS:
The animals received an oral dose of 5 mg/kg MPH or normal saline, as the vehicle, on a daily basis for 30 days. Y-maze test, passive avoidance, Barnes maze and field potential recording were conducted. Western blot for detecting the neurotrophic factor of GDNF and immunohistochemistry of astrogliosis were performed.
RESULTS:
Our results revealed that MPH treatment suppressed the willingness of rats to explore new environments. Also, it had no effect on improving long-term potentiation, long-term memory and spatial memory in the MPH group as opposed to the control group. There was also a significant increase of astrogliosis in the treated rats' hippocampi. On the other hand, there was not a significant relationship between MPH administration and the decrement of the GDNF level.
CONCLUSION:
We encourage the need to conduct more research on the adverse effects of MPH on the brain.
AuthorsGholam Hossein Meftahi, Maral Moafi, Seyed Hamidreza Mirbehbahani, Farid Fotouhi, Hossein Toreyhi, Samira Ezi, Fakhroddin Aghajanpour, Ali Forouzannia, Mahdi Eskandarian Boroujeni, Tahmineh Peirouvi, Hojjat Allah Abbaszadeh, Abbas Aliaghaei
JournalJournal of chemical neuroanatomy (J Chem Neuroanat) Vol. 108 Pg. 101818 (10 2020) ISSN: 1873-6300 [Electronic] Netherlands
PMID32485223 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Elsevier B.V. All rights reserved.
Chemical References
  • Central Nervous System Stimulants
  • Glial Cell Line-Derived Neurotrophic Factor
  • Methylphenidate
Topics
  • Animals
  • Central Nervous System Stimulants (pharmacology)
  • Glial Cell Line-Derived Neurotrophic Factor (metabolism)
  • Gliosis (chemically induced)
  • Hippocampus (drug effects, metabolism)
  • Male
  • Maze Learning (drug effects)
  • Memory (drug effects)
  • Methylphenidate (pharmacology)
  • Motor Activity (drug effects)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: